Insider Selling: Labcorp (NYSE:LH) EVP Sells 548 Shares of Stock

Labcorp Holdings Inc. (NYSE:LH) EVP Der Vaart Sandra Van sold 548 shares of Labcorp stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $284.91, for a total value of $156,130.68. Following the sale, the executive vice president directly owned 2,579 shares in the company, valued at $734,782.89. The trade was a 17.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Labcorp Price Performance

Shares of Labcorp stock traded down $6.82 during midday trading on Tuesday, hitting $279.65. 102,507 shares of the company were exchanged, compared to its average volume of 762,002. The firm has a 50 day simple moving average of $269.13 and a 200-day simple moving average of $270.10. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.42 and a quick ratio of 1.23. The firm has a market cap of $23.04 billion, a P/E ratio of 26.74, a PEG ratio of 1.97 and a beta of 1.01. Labcorp Holdings Inc. has a 52 week low of $209.38 and a 52 week high of $293.72.

Labcorp (NYSE:LH) last released its quarterly earnings data on Tuesday, February 17th. The medical research company reported $4.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.95 by $0.12. Labcorp had a return on equity of 16.16% and a net margin of 6.28%.The firm had revenue of $3.52 billion during the quarter, compared to analyst estimates of $3.56 billion. During the same period in the prior year, the company posted $3.45 earnings per share. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. Labcorp has set its FY 2026 guidance at 17.550-18.250 EPS. Research analysts forecast that Labcorp Holdings Inc. will post 16.01 earnings per share for the current year.

Labcorp Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 12th. Shareholders of record on Friday, February 27th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, February 27th. Labcorp’s dividend payout ratio is currently 27.53%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Caldwell Trust Co bought a new position in shares of Labcorp during the second quarter valued at $25,000. Financial Gravity Companies Inc. bought a new position in Labcorp during the 2nd quarter worth $26,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Labcorp in the 4th quarter valued at about $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Labcorp in the fourth quarter valued at about $27,000. Finally, JPL Wealth Management LLC acquired a new position in shares of Labcorp in the third quarter worth approximately $28,000. Institutional investors own 95.94% of the company’s stock.

Analyst Ratings Changes

LH has been the topic of a number of research analyst reports. Robert W. Baird increased their price target on Labcorp from $313.00 to $326.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Weiss Ratings upgraded Labcorp from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, February 10th. JPMorgan Chase & Co. raised their target price on Labcorp from $319.00 to $330.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. Piper Sandler upped their price target on shares of Labcorp from $270.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 24th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Labcorp in a report on Tuesday, February 17th. Ten investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $304.42.

Labcorp Company Profile

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.